CFRA Maintains Buy Opinion On Shares Of Micron Technology, Inc.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We boost our 12-month target to $94 from $85, on P/E of 13x our CY 25 EPS view, near MU’s long-term historical average. We narrow our FY 24 (Aug.) loss per share estimate to $0.51 from $1.12 and raise FY 25’s EPS to $6.14 from $5.91. MU posts Nov-Q loss per share of $0.95 vs. $0.04 loss, beating the $1.01 consensus loss view. Sales rose 18% from Aug-Q, better than expected, led by 24% growth in DRAM while NAND rose a more modest 2%. We are encouraged by improving gross margin trajectory (13% seen in Feb-Q vs. 6% consensus) and see a path towards 35%-40% by CY 24 end as well as return to profitability by the May-Q, driven by higher pricing, higher utilization, and better mix. […]

CFRA Maintains Buy Opinion On Shares Of Micron Technology, Inc. Read Post »

Nike Earnings Likely Won’t Be Stellar. Wall Street Is Excited About the Stock Anyway. — Barrons.com

By Sabrina Escobar Wall Street is feeling more upbeat about Nike’s 2024 outlook — but analysts are a lot more tepid about the retailer’s earnings report coming Thursday afternoon. Over the past few months, Street sentiment on Nike stock has been improving. Investors have rallied behind the prospect of bigger margins now that the company is seeing better freight costs and less discounting. Just last week, Citi analyst Paul Lejuez upgraded shares of Nike to Buy from Neutral, arguing that Nike is an “attractive margin recovery story” amid a choppy macroeconomic environment. And earlier in December, Wells Fargo analyst Ike Boruchow added Nike to his top picks list, swapping out competitor Lululemon Athletica in the process. “We simply believe the recovery characteristics and self-help story now beginning at [Nike] make for a more compelling long idea into 2024,” Boruchow wrote at the time. But first, the company has to wrap

Nike Earnings Likely Won’t Be Stellar. Wall Street Is Excited About the Stock Anyway. — Barrons.com Read Post »

Micron Technology Fiscal Q1 Tops Estimates

Micron Technology (MU) reported a fiscal Q1 non-GAAP diluted loss late Wednesday of $0.95 per share, compared with a loss of $0.04 a year earlier. Analysts polled by Capital IQ expected a loss of $1.01 normalized. Revenue for the quarter that ended Nov. 30 was $4.73 billion, up from $4.09 billion a year earlier. Analysts surveyed by Capital IQ expected $4.63 billion. The company said it expects a fiscal Q2 non-GAAP loss of $0.28 plus/minus $0.07. Analysts expect a loss of $0.61 normalized. Micron expects revenue of $5.30 billion-plus/minus $200 million for the quarter. Analysts expect $5.05 billion.

Micron Technology Fiscal Q1 Tops Estimates Read Post »

Micron Technology (NASDAQ:MU) Stock Analyst Ratings

Micron Technology (NASDAQ:MU) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/21/2023 14.42% Barclays $85 → $95 Maintains Overweight 12/21/2023 20.44% Keybanc $90 → $100 Maintains Overweight 12/19/2023 20.44% Rosenblatt → $100 Reiterates Buy → Buy 12/18/2023 8.39% BMO Capital $80 → $90 Maintains Outperform 12/18/2023 34.89% Susquehanna $90 → $112 Maintains Positive 12/15/2023 -8.47% Stifel $72 → $76 Maintains Hold 12/15/2023 14.42% B of A Securities $77 → $95 Upgrades Neutral → Buy 12/11/2023 8.39% UBS $76 → $90 Maintains Buy 12/06/2023 3.58% Mizuho $82 → $86 Maintains Buy 11/29/2023 5.99% Citigroup $85 → $88 Maintains Buy 11/29/2023 -1.24% Raymond James $76 → $82 Maintains Outperform 11/29/2023 2.37% Barclays $80 → $85 Maintains Overweight 11/29/2023 2.37% Needham $75 → $85 Maintains Buy 11/27/2023 -13.89% Morgan Stanley $58.5 → $71.5 Maintains Underweight 09/28/2023 -29.54% Morgan Stanley $58.5 → $58.5 Reiterates Underweight →

Micron Technology (NASDAQ:MU) Stock Analyst Ratings Read Post »

Salesforce (NYSE:CRM) stock Analyst Ratings

Salesforce (NYSE:CRM) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/21/2023 31.84% Morgan Stanley $290 → $350 Upgrades Equal-Weight → Overweight 12/20/2023 5.47% Wells Fargo → $280 Downgrades Overweight → Equal-Weight 12/18/2023 18.65% Wolfe Research → $315 Upgrades Peer Perform → Outperform 12/01/2023 9.24% Argus Research $275 → $290 Maintains Buy 11/30/2023 9.24% Evercore ISI Group $275 → $290 Maintains Outperform 11/30/2023 13% Raymond James $280 → $300 Maintains Strong Buy 11/30/2023 13% Stifel $275 → $300 Maintains Buy 11/30/2023 3.59% Truist Securities → $275 Reiterates Buy → Buy 11/30/2023 -2.06% JP Morgan $240 → $260 Maintains Overweight 11/30/2023 10.37% JMP Securities $275 → $293 Maintains Market Outperform 11/30/2023 5.47% Mizuho $255 → $280 Maintains Buy 11/30/2023 3.59% Oppenheimer $250 → $275 Maintains Outperform 11/30/2023 4.34% BMO Capital $252 → $277 Maintains Outperform 11/30/2023 9.24% Morgan Stanley $278 → $290 Maintains Equal-Weight

Salesforce (NYSE:CRM) stock Analyst Ratings Read Post »

Eli Lilly Company (NYSE: LLY) Stock Analyst Ratings

Eli Lilly  Company (NYSE: LLY) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/21/2023 6.79% Daiwa Capital → $610 Downgrades Buy → Outperform 11/29/2023 13.79% Truist Securities → $650 Reiterates Buy → Buy 11/20/2023 10.29% Cantor Fitzgerald → $630 Reiterates Overweight → Overweight 11/17/2023 10.29% Cantor Fitzgerald → $630 Reiterates Overweight → Overweight 11/15/2023 10.29% Cantor Fitzgerald → $630 Reiterates Overweight → Overweight 11/09/2023 -6.34% Deutsche Bank → $535 Initiates Coverage On → Hold 11/08/2023 — JP Morgan Reiterates → Overweight 11/03/2023 26.39% Morgan Stanley $673 → $722 Maintains Overweight 10/23/2023 18.16% Citigroup $525 → $675 Maintains Buy 10/23/2023 10.29% Cantor Fitzgerald → $630 Reiterates Overweight → Overweight 10/20/2023 24.29% UBS $612 → $710 Assumes Buy → Buy 10/11/2023 17.81% Morgan Stanley $640 → $673 Maintains Overweight 10/09/2023 10.29% Cantor Fitzgerald → $630 Reiterates Overweight → Overweight 10/09/2023 13.79% Wells Fargo $615

Eli Lilly Company (NYSE: LLY) Stock Analyst Ratings Read Post »

Home Depot (NYSE: HD) Stock Analyst Ratings

Home Depot (NYSE: HD) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/20/2023 0.41% Stifel $306 → $355 Maintains Hold 12/08/2023 0.7% Truist Securities $340 → $356 Maintains Buy 11/15/2023 -3.83% Guggenheim $360 → $340 Maintains Buy 11/15/2023 -15.43% RBC Capital $303 → $299 Maintains Sector Perform 11/15/2023 1.83% Oppenheimer → $360 Reiterates Outperform → Outperform 11/15/2023 -3.83% Truist Securities $341 → $340 Maintains Buy 11/15/2023 -5.24% Morgan Stanley $350 → $335 Maintains Overweight 11/15/2023 -8.07% Telsey Advisory Group → $325 Reiterates Market Perform → Market Perform 11/13/2023 -13.45% Stifel $350 → $306 Maintains Hold 11/07/2023 -14.3% RBC Capital → $303 Initiates Coverage On → Sector Perform 11/07/2023 -8.07% Telsey Advisory Group $330 → $325 Maintains Market Perform 10/05/2023 -3.55% Truist Securities $372 → $341 Maintains Buy 10/04/2023 -6.66% Telsey Advisory Group $335 → $330 Maintains Market Perform 09/22/2023 3.24% HSBC →

Home Depot (NYSE: HD) Stock Analyst Ratings Read Post »

Accenture (NYSE:ACN) stock Analyst Ratings

Accenture (NYSE:ACN) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/20/2023 7.07% UBS $333 → $365 Maintains Neutral 12/14/2023 5.6% Wedbush $330 → $360 Maintains Outperform 11/16/2023 20.27% Redburn Atlantic → $410 Initiates Coverage On → Buy 11/07/2023 -2.32% UBS → $333 Initiates Coverage On → Neutral 09/29/2023 -0.26% RBC Capital → $340 Reiterates Outperform → Outperform 09/29/2023 2.67% BMO Capital $360 → $350 Maintains Market Perform 09/29/2023 -12% TD Cowen $312 → $300 Maintains Market Perform 09/29/2023 -5.54% Baird $332 → $322 Maintains Neutral 09/29/2023 -12% Piper Sandler $312 → $300 Maintains Neutral 09/27/2023 5.6% BMO Capital $355 → $360 Maintains Market Perform 09/26/2023 -3.2% Wedbush → $330 Reiterates Outperform → Outperform 09/22/2023 -8.48% Piper Sandler $314 → $312 Maintains Neutral 09/18/2023 5.02% Citigroup $358 → $358 Maintains Buy 09/12/2023 -8.48% TD Cowen $300 → $312 Maintains Market Perform 09/12/2023 4.14%

Accenture (NYSE:ACN) stock Analyst Ratings Read Post »

Key Boeing Supplier Nabs an Upgrade. There’s a Good Reason to Buy Its Stock. — Barrons.com

Embattled Boeing supplier Spirit AeroSystems Holdings caught an upgrade. It isn’t a bullish call, but there is one compelling thing about its shares that investors should consider. On Wednesday, Morgan Stanley analyst Kristine Liwag upgraded shares of Spirit Aero to Hold from Sell. She raised her price target to $35 a share from $22. It isn’t a Buy, but any upgrade is a relief for Spirit Aero investors. Things have been incredibly difficult for the fuselage supplier in recent years. Shares are down about 65% from April 2019, just after the Boeing 737 MAX was grounded worldwide following two deadly crashes. After the MAX grounding came Covid-19, which reduced demand for air travel. Spirit Aero has used more than $1 billion since the MAX grounding just to keep its business afloat. Free cash flow is expected to return in 2024. That and improving demand for air travel prompted the ratings

Key Boeing Supplier Nabs an Upgrade. There’s a Good Reason to Buy Its Stock. — Barrons.com Read Post »

Scroll to Top